MCC 18613 Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults

Grant

Total Award Amount

  • 32500.00
  • Direct Costs

  • 25000.00
  • Sponsor Award Id